Published on 22/12/2025
Best Practices for Conducting Remote Due Diligence in Clinical Trial Vendor Assessments
Introduction: Why Remote Due Diligence Is Increasing
The COVID-19 pandemic accelerated the shift toward remote oversight in clinical research. Sponsors and CROs increasingly rely on virtual tools to conduct vendor assessments, audits, and qualifications without physical site visits. Even in the post-pandemic environment, remote due diligence remains essential for efficiency, cost reduction, and global vendor oversight. Regulators including FDA and EMA have acknowledged the role of remote methods but emphasize that sponsors remain accountable for vendor compliance, regardless of assessment format. This makes it critical to establish standardized best practices for remote due diligence in vendor qualification processes.
1. Regulatory Expectations for Remote Due Diligence
Global regulatory frameworks recognize remote assessments but require accountability:
- ICH-GCP E6(R2): Sponsors must maintain oversight of outsourced activities, whether audits are on-site or remote.
- FDA Guidance (2021 Remote Regulatory Assessments): Encourages use of electronic systems but requires full documentation and traceability.
- EMA Reflection Papers: Permit remote audits if evidence demonstrates equal rigor to on-site evaluations.
- MHRA Remote GCP Inspections: Stress that inspection readiness must not be compromised by remote formats.
Remote due diligence must meet the same quality standards as traditional on-site evaluations.
2. Tools
Effective remote assessments rely on secure technology platforms:
- Document Sharing Platforms: eTMF portals, secure FTPs, or validated cloud repositories for SOPs, training records, and quality manuals.
- Video Conferencing: For interviews with vendor staff and virtual site tours.
- Electronic Questionnaires: Web-based due diligence checklists and vendor self-assessments.
- Data Rooms: Centralized platforms for controlled access to sensitive vendor information.
- Cybersecurity Tools: Encryption, multi-factor authentication, and activity tracking for remote access.
3. Remote Due Diligence Process
A structured remote due diligence process typically includes:
- Pre-Assessment Planning: Define scope, critical risk areas, and documentation requirements.
- Document Review: Evaluate SOPs, regulatory inspection histories, and CAPA records.
- Interviews and Virtual Meetings: Assess vendor culture, staff training, and communication effectiveness.
- Virtual Site Tours: Use live video or pre-recorded tours of labs, data centers, and facilities.
- Risk Scoring: Apply quantitative or qualitative scoring models to classify vendor risk.
- Reporting: Document findings, CAPAs, and qualification outcomes in the Trial Master File (TMF).
4. Sample Remote Due Diligence Checklist
| Domain | Remote Assessment Activity | Evidence Required |
|---|---|---|
| Quality Management | Review SOP index via shared portal | Validated SOPs, version control logs |
| Training Records | Interview staff, review GCP training logs | Signed training certificates |
| IT Systems | Remote validation checks | System validation reports, audit trails |
| Facilities | Virtual site tour | Video footage of storage, labs, server rooms |
| Regulatory History | Cross-check inspection history | Copies of FDA 483s, EMA letters |
5. Case Study: Remote Due Diligence for a Central Lab
Scenario: A sponsor qualifying a central laboratory during the pandemic used remote due diligence with video conferencing, document sharing, and third-party certifications.
Outcome: The lab was successfully qualified, with CAPAs documented for minor SOP gaps. During a later EMA inspection, the sponsor’s remote due diligence records were reviewed and deemed acceptable evidence of oversight.
6. Best Practices for Remote Due Diligence
- Plan remote assessments with the same rigor as on-site audits.
- Validate IT platforms used for document sharing and video tours.
- Involve cross-functional teams (QA, IT, Clinical Operations).
- Ensure data privacy compliance (GDPR, HIPAA, 21 CFR Part 11).
- Archive all records and communications in the TMF.
- Reassess vendors periodically to verify continuous compliance.
Conclusion
Remote due diligence has become an integral part of vendor qualification in clinical trials. By leveraging secure technologies, structured processes, and risk-based oversight, sponsors can maintain regulatory compliance and operational efficiency while reducing travel and cost. Documentation remains the cornerstone—remote assessments must produce the same level of evidence as traditional audits to ensure inspection readiness and safeguard trial quality.